NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹54 Cr | ₹35 Cr | ₹68 Cr | ₹80 Cr | ₹1,975,921 Cr |
What is the latest Operating Profit of NGL FINECHEM ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹54 Cr |
| Mar2024 | ₹35 Cr |
| Mar2023 | ₹68 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹1,975,921 Cr |
How is Operating Profit of NGL FINECHEM Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹54 Cr | 53.73 | |
| Mar2024 | ₹35 Cr | -48.74 | |
| Mar2023 | ₹68 Cr | -14.87 | |
| Mar2022 | ₹80 Cr | -100.00 | |
| Mar2021 | ₹1,975,921 Cr | - | |
Compare Operating Profit of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,420.8 Cr | 3.3% | 55.9% | 11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 3.3% |
55.9% |
11.5% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses